Trxade Health Profit Margin

Trxade Health (MEDS) currently reports a profit margin of -9173.52% as of June 2026. That compares with 7453.12% in the prior-year period — down 223.1% year over year. That is below the Finance sector average of 17.05%. Use the charts on this page to explore Trxade Health's profit margin history and peer comparisons.

Trxade Health's profit margin decreased from 7453.12% to -9173.52% — a 223.1% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Trxade Health's profit margin of -9173.52% is lower than the Finance sector average of 17.05%. That is roughly 53911.6% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' profit margin, but Trxade Health's current -9173.52% should be judged against Finance norms (sector average: 17.05%) and against MEDS's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current profit margin of -9173.52%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Finance average is 17.05%. From there, open related valuation or income-statement pages for Trxade Health, and consider following MEDS for alerts when major investors trade the stock.